SOURCE: Recordati S.p.A.

August 29, 2006 11:31 ET

RECORDATI appoints new General Manager Pharmaceuticals Italy

MILANO, MI -- (MARKET WIRE) -- August 29, 2006 -- Milan, 29 August 2006 - Recordati announces the appointment of Dr. Andrea Breschi to the position of General Manager Pharmaceuticals Italy. Dr. Breschi, 48, was born in Perugia (Italy), has a degree in Medicine and twenty years of experience in the pharmaceuticals sector both in Italy as well as international. As from 2001 he has been General Manager of Malesci S.p.A., a Menarini group company.

Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), dedicated to the research, development, manufacturing and marketing of pharmaceuticals, with headquarters in Milan, Italy, operations in the main European countries, and a total staff of over 2,000. A European field force of over 1,000 medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas. Recordati's current and growing coverage of the European pharmaceutical market makes it a partner of choice for new product licenses from companies which do not have European marketing organizations. Recordati is committed to the research of new drug entities within the cardiovascular and urogenital therapeutic areas in which its research team has proven scientific competence and a track record of discovery and development of original drugs, the most recent of which, lercanidipine, a latest generation calcium channel blocker for the treatment of hypertension, is the company's leading product. Consolidated revenue for 2005 was EUR 576.1 million, operating income was EUR 111.1 million and net income was EUR 64.5 million.

For further information:

Recordati website:

Investor Relations

Marianne Tatschke



Media Relations

Claudio Rossetti (Echo Comunicazione d'Impresa)

(39)02 62694736


This information is provided by CompanynewsGroup

Contact Information